• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Drainage Patterns After Mastectomy May Signal Lasting Seroma Risk

by
October 28, 2026
in Cancer, Health
Reading Time: 2 mins read
0
Drainage Patterns After Mastectomy May Signal Lasting Seroma Risk

Drainage Patterns After Mastectomy May Signal Lasting Seroma Risk

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Adults undergoing modified radical mastectomy with axillary lymph node dissection sometimes develop a persistent seroma, a collection of fluid that can prolong drainage and slow recovery.

The single-center study included 306 adults with unilateral invasive breast cancer who underwent modified radical mastectomy with level I–II axillary lymph node dissection between 2021 and 2024. The researchers used latent class mixed-effects models to identify trajectories of daily combined drainage volume during the first seven postoperative days.

Three distinct trajectories emerged. A rapid-decline group included 123 patients, a moderate-decline group included 127 patients, and a persistently high-output group included 56 patients.

Persistent seroma on postoperative day 30 occurred in 7.3 percent of the rapid-decline group, 19.7 percent of the moderate-decline group, and 57.1 percent of the persistently high-output group, a difference the authors reported as statistically significant with P < 0.001.

To account for other factors, the researchers used Firth penalized-likelihood logistic regression, adjusting for age, body mass index, diabetes mellitus, neoadjuvant systemic therapy, resected specimen weight, operative time, and the number of dissected lymph nodes. Relative to the rapid-decline trajectory, the adjusted odds ratio for persistent seroma was 2.58 (95 percent confidence interval, 1.10–6.07) for the moderate-decline trajectory and 11.44 (95 percent confidence interval, 3.92–33.37) for the persistently high-output trajectory.

The association for the persistently high-output trajectory remained strong across sensitivity analyses that addressed uncertainty in class assignment, the outcome definition, retention of the original drain, pathologic T category, and the operating surgeon. The association for the moderate-decline trajectory was less stable across these analyses.

The study also compared trajectory classification with simpler drainage measures in exploratory complete-case models. The trajectory model and a model based on postoperative day 7 drainage showed similar discrimination. Adding trajectory class provided little incremental information beyond day 7 drainage, but it improved model fit and discrimination beyond 7-day cumulative drainage and beyond the relative decline from postoperative day 1 to day 7.

The authors concluded that persistently high output was consistently associated with persistent seroma on postoperative day 30, but they cautioned that trajectory classification should remain a research-oriented postoperative risk-stratification variable. They noted that the incremental clinical value of trajectory classification over the simpler day 7 drainage measurement remains uncertain and requires prospective validation.

According to the study’s conclusions, clinical application would require multicenter external validation, assessment of class-assignment reproducibility, calibration, clinically meaningful thresholds, and evaluation of clinical utility. As a single-center retrospective analysis, the findings describe associations observed in one institution’s patient population and do not establish that trajectory classification improves patient outcomes.

Subject of Research: Drainage volume decline trajectories after modified radical mastectomy and their association with persistent seroma.

Article Title: Association of drainage volume decline trajectories during the first 7 postoperative days with persistent seroma on postoperative day 30 after modified radical mastectomy for breast cancer

Article References: Bian, Q., Wu, X., & Cui, M. (2026). Association of Drainage Volume Decline Trajectories During the First 7 Postoperative Days With Persistent Seroma on Postoperative Day 30 After Modified Radical Mastectomy for Breast Cancer. Frontiers in Oncology, 16, 1981532. https://doi.org/10.3389/fonc.2026.1981532

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1981532

Keywords: breast cancer, modified radical mastectomy, axillary lymph node dissection, persistent seroma, drainage trajectory, postoperative drainage, risk stratification, retrospective study, surgical outcomes, seroma, Association, drainage

News Source: Nathaniel Bowman. (October 28, 2026). Drainage Patterns After Mastectomy May Signal Lasting Seroma Risk. Scienmag.

Tags: Associationaxillary lymph node dissectionBreast Cancerdrainagedrainage trajectorymodified radical mastectomypersistent seromapostoperative drainageRetrospective studyrisk stratificationseromasurgical outcomes
Share12Tweet7Share2ShareShareShare1

Related Posts

Neutrophils Shift Metabolism in a Triple-Negative Breast Cancer Coculture Model

Neutrophils Shift Metabolism in a Triple-Negative Breast Cancer Coculture Model

October 28, 2026
One-Week Smartphone Intervention for Autistic Adults Falls Short in First Trial

One-Week Smartphone Intervention for Autistic Adults Falls Short in First Trial

October 28, 2026

Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

October 28, 2026

Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

October 28, 2026

POPULAR NEWS

  • Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    Systematic review maps end-of-life psychosocial and spiritual needs in physical disability

    29 shares
    Share 12 Tweet 7
  • Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening

    29 shares
    Share 12 Tweet 7
  • FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia

    29 shares
    Share 12 Tweet 7
  • Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neutrophils Shift Metabolism in a Triple-Negative Breast Cancer Coculture Model

Melatonin eases drought injury in maize seedlings, with effects differing by dose

One-Week Smartphone Intervention for Autistic Adults Falls Short in First Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.